About Allison
Allison was diagnosed with PH when she was a senior in high school in 2015. After she started on triple therapy, including subcutaneous remodulin, she was very responsive to treatment. After seven years on infused therapies, she transitioned to a combination of inhaled/oral treatment.
Since diagnosis, Allison has attended nursing school and has traveled to Asia, Europe, Australia, New Zealand, the Caribbean and Mexico. She works full time as a pediatric cardiac ICU nurse, fulfilling her dream of working with infants and children with PH. Allison serves on the PHA Board of Trustees.
Treatment familiarity:
- Ambrisentan (Letairis)
- Inhaled treprostinil (Tyvaso)
- Macitentan (Opsumit)
- Selexipag (Uptravi)
- Subcutaneous treprostinil
- Tadalafil (Adcirca)
Other areas of experience:
- Oxygen support
- Titration support
Preferred communication methods:
Preferred languages:
- English